SOLIGENIX, INC. Retained Earnings
SOLIGENIX, INC. (SNGX) had Retained Earnings of -$249.86 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$249.86M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$247.88M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$245.05M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$242.15M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$249.86M 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$247.88M 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$245.05M 10-Q · filed 2026-08-07 |
| 2025-09-30 | -$242.15M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$239.62M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$237.21M 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$233.97M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$230.98M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$229.26M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$227.62M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$225.70M 10-K · filed 2025-03-21 |
| 2023-09-30 | -$223.88M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$222.22M 10-Q · filed 2023-08-21 |
| 2023-03-31 | -$220.61M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$219.56M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$215.81M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$212.50M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$210.11M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$205.77M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$201.06M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$197.47M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$195.58M 10-Q · filed 2021-05-18 |
| 2020-12-31 | -$193.21M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$187.67M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$185.88M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$183.11M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$175.53M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$172.65M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$169.93M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$167.81M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$166.17M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$163.07M 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$161.20M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$159.65M 10-Q · filed 2018-05-11 |
| 2017-12-31 | -$157.27M 10-K · filed 2019-03-26 |
| 2017-09-30 | -$155.13M 10-Q · filed 2017-11-06 |
| 2017-06-30 | -$154.17M 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$151.86M 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$150.12M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$149.79M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$148.12M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$148.03M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$146.88M 10-K · filed 2017-03-27 |
| 2015-09-30 | -$144.82M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$147.59M 10-Q · filed 2015-08-12 |
| 2015-03-31 | -$143.62M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$139.05M 10-K · filed 2016-03-24 |
| 2014-09-30 | -$140.97M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$136.62M 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$135.67M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$132.34M 10-K · filed 2015-03-25 |
| 2013-09-30 | -$133.33M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$126.77M 10-Q · filed 2013-08-12 |
| 2013-03-31 | -$123.37M 10-Q · filed 2013-05-03 |
| 2012-12-31 | -$122.28M 10-K · filed 2014-03-26 |
| 2012-09-30 | -$121.29M 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$120.54M 10-Q · filed 2012-08-10 |
| 2012-03-31 | -$119.56M 10-Q · filed 2012-05-14 |
| 2011-12-31 | -$118.12M 10-K · filed 2013-02-26 |
| 2011-09-30 | -$117.19M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$119.39M 10-Q · filed 2011-08-12 |
| 2010-12-31 | -$115.74M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |